Analysis of sarcopenia in patients with liver disorder

Analysis of sarcopenia in patients with liver disorder - sarcopenia in patients with liver disorder

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030755

Enrollment

1000

Registered

2018-01-10

Start date

2017-03-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with liver disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 patients with liver disorder 2 20 year old or more than 20 years old 3 patients who agree to paticipate this study or disagree to paticipate this study.

Exclusion criteria

Exclusion criteria: patients judged to be inappropriate to participate in the study by the primary physician

Design outcomes

Primary

Measure	Time frame
To investigate Frequency of sarcopenia in Patients with liver disorder	—

Secondary

Measure	Time frame
1To investigate association between PMI and Body composition analysis 2 To investigate cause of liver disease in patients with Sarcopenia 3 To investigate the effects of BCAA, carnitine and diuretic drug administration on sacropenia	—

Countries

Japan

Contacts

Public ContactGoki Suda

Graduate School of Medicine, Hokkaido University Department of Gastroenterology and Hepatology

gsudgast@pop.med.hokudai.ac.jp+81-11-716-1161

Outcome results